购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Antibacterial
    (1)
  • Drug Metabolite
    (1)
  • EGFR
    (1)
  • Others
    (8)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 5日内发货
    (8)
  • 35日内发货
    (1)
  • 6-8周
    (3)
筛选
搜索结果
TargetMol产品目录中 "

ag 18

"的结果
  • 抑制剂&激动剂
    10
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    8
    TargetMol | Recombinant_Protein
  • Tyrphostin 23
    Tyrphostin A23, TX 825, RG-50810, AG18
    T2063118409-57-7
    Tyrphostin 23 (AG18) 是一种EGFR 抑制剂,IC50值为35 μM。
    • ¥ 241
    现货
    规格
    数量
  • AG 1812
    AG-1812, AG1812
    T29697114559-57-8
    AG-1812 is a bio-active chemical.
    • ¥ 10600
    期货
    规格
    数量
  • AG-1812 free base
    UNII-6RI44GB0V9, Lansoprazole disulfide active metabolite, HE078804, AC1MIZB6
    T29704700341-80-6
    ABT-1812 is a bio-active chemical.
    • ¥ 10600
    期货
    规格
    数量
  • AG-1859
    AG 001859,AG 1859,AG-001859,AG001859
    T26571478410-84-3
    AG-1859, an HIV protease inhibitor, is used potentially for the treatment of HIV infection.
    • ¥ 11700
    6-8周
    规格
    数量
  • (1R,4S)-Yimitasvir diphosphate
    (1R,4S)-Emitasvir diphosphate, (1R,4S)-DAG-181 diphosphate
    T786692734870-15-4
    Yimitasvir (Emitasvir) diphosphate是一口服活性HCV NS5A抑制剂,适用于研究慢性丙型肝炎病毒感染。
    • 待询
    8-10周
    规格
    数量
  • AG-1801
    UNII-WYN000A4MH,AG1801,AG 1801
    T29703204010-55-9
    AG-1801 is a bio-active chemical.
    • ¥ 10600
    期货
    规格
    数量
  • AG-183
    T21783122520-90-5
    (Z)-Tyrphostin A51 是 Lanoconazole A51 的 Z 构型形式。Tyrphostin A51 是一种有效的蛋白酪氨酸激酶 (PTK)抑制剂,以剂量依赖性方式抑制原代星形胶质细胞培养物中 [3H]牛磺酸的体积敏感释放。Tyrphostin A51 显着降低细胞酪氨酰磷酸化水平。Tyrphostin A51 抑制基础和 EGF 诱导的人骨细胞增殖。
    • 待估
    35日内发货
    规格
    数量
  • Lansoprazole sulfide
    兰索拉唑硫醚, AG-1777, AG1777
    T21128103577-40-8
    Lansoprazole sulfide (AG-1777,兰索拉唑硫醚)是Lansoprazole的活性代谢物,具有相似的活性。Lansoprazole是一种质子泵抑制剂和抗结核剂,对 Mycobacterium tuberculosis 的 IC50= 0.59 µM。
    • ¥ 528
    现货
    规格
    数量
  • AG-012986
    T69196486414-35-1
    AG-012986 is a multitargeted cyclin-dependent kinase (CDK) inhibitor active against CDK1, CDK2, CDK4 6, CDK5, and CDK9, with selectivity over a diverse panel of non-CDK kinases. AG-012986 showed antiproliferative activities in vitro with IC(50)s of <100 nmol L in 14 of 18 tumor cell lines. In vivo, significant antitumor efficacy induced by AG-012986 was seen (tumor growth inhibition, >83.1%) in 10 of 11 human xenograft tumor models. AG-012986 also showed dose-dependent retinoblastoma Ser(795) hypophosphorylation, cell cycle arrest, decreased Ki-67 tumor staining, and apoptosis in conjunction with antitumor activity.
    • ¥ 10600
    6-8周
    规格
    数量
  • AG-012986 HCl
    T69197486414-32-8
    AG-012986 HCl is a multitargeted cyclin-dependent kinase (CDK) inhibitor active against CDK1, CDK2, CDK4 6, CDK5, and CDK9, with selectivity over a diverse panel of non-CDK kinases. AG-012986 HCl showed antiproliferative activities in vitro with IC(50)s of <100 nmol L in 14 of 18 tumor cell lines. In vivo, significant antitumor efficacy induced by AG-012986 HCl was seen (tumor growth inhibition, >83.1%) in 10 of 11 human xenograft tumor models. AG-012986 HCl also showed dose-dependent retinoblastoma Ser(795) hypophosphorylation, cell cycle arrest, decreased Ki-67 tumor staining, and apoptosis in conjunction with antitumor activity.
    • ¥ 10600
    6-8周
    规格
    数量
没有更多数据了